ZIMBERELIMAB

Search structure
Synonyms:
Status: Phase 3
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: ZBL7O904IL

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Programmed cell death protein 1 inhibitor

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Carcinoma, Non-Small-Cell Lung 3 D002289 ClinicalTrials
Uterine Cervical Neoplasms 3 D002583 ClinicalTrials
Hodgkin Disease 3 D006689 ClinicalTrials
Carcinoma, Non-Small-Cell Lung 3 D002289 ClinicalTrials
Adenocarcinoma 3 D000230 ClinicalTrials
Uterine Cervical Neoplasms 3 D002583 ClinicalTrials
Urinary Bladder Neoplasms 2 D001749 ClinicalTrials
Melanoma 2 D008545 ClinicalTrials
Rectal Neoplasms 2 D012004 ClinicalTrials
Prostatic Neoplasms, Castration-Resistant 2 D064129 ClinicalTrials
Prostatic Neoplasms 2 D011471 ClinicalTrials
Carcinoma, Pancreatic Ductal 2 D021441 ClinicalTrials
Prostatic Neoplasms 2 D011471 ClinicalTrials
Carcinoma, Squamous Cell 2 D002294 ClinicalTrials
Neoplasms 2 D009369 ClinicalTrials
Pancreatic Neoplasms 2 D010190 ClinicalTrials
Neoplasms 2 D009369 ClinicalTrials
Breast Neoplasms 2 D001943 ClinicalTrials
Pancreatic Neoplasms 2 D010190 ClinicalTrials
Cholangiocarcinoma 2 D018281 ClinicalTrials
Adenocarcinoma, Clear Cell 1 D018262 ClinicalTrials
Glioblastoma 1 D005909 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4297856
FDA SRS ZBL7O904IL
CONTENTS